Bulgarian Drug Maker Sopharma Starts Sales in Austria.
Nivalin, a plant-based medicine that treats neurological diseases, has become the first Bulgarian medicine to be registered in Austria, a real breakthrough on what is considered to be one of the most conservative markets in Europe. In Austria the medicine has been registered under the trademark Nivaject.
The news comes nearly a year after the company announced plans to sell in the United States its anti-smoking drug Tabex, a Sopharma trademark. For this purpose the company became a shareholder in a newly set up US company Extab.
In order to distribute Tabex in the US, the company needs the approval of the most stringent drug regulator in the world, the Food and Drug Administration (FDA).